Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 4, 2011, Pages 469-478

  Chan, Vincent ^a,b   Fenning, Andrew ^a   Levick, Scott P ^a   Loch, David ^a   Chunduri, Prasad ^a   Iyer, Abishek ^a   Teo, Yi Ling ^a   Hoey, Andrew ^b   Wilson, Kathleen ^c   Burstow, Darryl ^c   Brown, Lindsay ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Ageing; gender; heart failure; hypertension; remodeling; spontaneously hypertensive rats

Indexed keywords

SUPEROXIDE;

ACTION POTENTIAL; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ERYTHROCYTE; FEMALE; GLUCOSE TOLERANCE; HEART FAILURE; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HYPERTENSION; MALE; MATURATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SYSTOLIC DYSFUNCTION;

AGE FACTORS; AGING; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; FIBROSIS; HEART FAILURE; HUMANS; HYPERTENSION; MALE; RATS; RATS, INBRED SHR; SEX FACTORS; SPECIES SPECIFICITY; SUPEROXIDES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 79955015336     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182102c3b     Document Type: Article

References (66)

1. Australian Institute of Health and Welfare (AIHW) Australia's health 2010. Australia's Health series no. 12. Cat. no. AUS 122. Canberra, Australia: AIHW 2010.
2. Australian Institute of Health and Welfare (AIHW). Impact of falling cardiovascular disease death rates: deaths delayed and years of life extended. Bulletin no. 70. Cat no. AUS 113. Canberra, Australia: AIHW; 2009.
3. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39:89-105. (Pubitemid 28322382)
4. Dubey RK, Oparil S, Imthurn B, et al. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688-708. (Pubitemid 34175262)
5. Halm MA, Penque S. Heart failure in women. Prog Cardiovasc Nurs. 2000;15:121-133.
6. Bing OH, Brooks WW, Robinson KG, et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. JMol Cell Cardiol. 1995;27:383-396.
7. Brooks WW, Bing OHL, Robinson KG, et al. Effect of angiotensin converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hyper-tensive rat. Circulation. 1997;96:4002-4010.
8. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. JAm Coll Cardiol. 2000;35:569-582. (Pubitemid 30167013)
9. Colucci WS. Molecular and cellular mechanisms of myocardial failure. AmJCardiol. 1997;80:L15-L25.
10. Brown L, Fenning A, Chan V, et al. Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ 2002;11: 167-173. (Pubitemid 36040767)
11. Brown L, Duce B, Miric G, et al. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. JAm Soc Nephrol. 1999;10(Suppl 11): S143-S148. (Pubitemid 29038179)
12. Fenning A, Harrison G, Rose'meyer R, et al. L-arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am JPhysiol. 2005;289:H1408-H1416. (Pubitemid 41368981)
13. Chan V, Hoey A, Brown L. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol. 2006; 148:902-908. (Pubitemid 44543607)
14. Wang H, Joseph JA. Quantifying cellular oxidative stress by dicholoro-fluorescein assay using microplate reader. Free Radic BiolMed. 1999;27: 612-616. (Pubitemid 29408648)
15. Kurtz TW, Montano M, Chan L, et al. Molecular evidence of genetic heterogeneity in Wistar-Kyoto rats: implications for research with the spontaneously hypertensive rat Hypertension. 1989;13:188-192. (Pubitemid 19060085)
16. Louis WJ, Howes LG Genealogy of the spontaneously hypertensive rat and Wistar-Kyoto rat strains: implications for studies of inherited hypertension. J Cardiovasc Pharmacol. 1990;16(Suppl 7): S1-S5.
17. Johnson ML, Ely DL, Turner ME. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension. 1992;19:425-427.
18. St Lezin E, Simonet L, Pravenec M, et al. Hypertensive strains and normotensive 'control strains. How closely are they related? Hypertension. 1992;19:419-424.
19. Benetos A, Poitevin P, Prost PL, et al. Life survival and cardiovascular structures following selective ß-blockade in spontaneously hypertensive rats. Am J Hypertens. 1994;7:186-192. (Pubitemid 24079129)
20. Linz W, Wohlfart P, Schoelkens BA, et al. Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension. 1999;34:291-295. (Pubitemid 29409230)
21. Pfeffer JM, Pfeffer MA, Fishbein MC, et al. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;237:H461-H468. (Pubitemid 10249649)
22. Conrad CH, Brooks WW, Robinson KG, et al. Impaired myocardial function in spontaneously hypertensive rats with heart failure. Am J Physiol. 1991;260(1pt 2):H136-H145.
23. Wallen WJ, Cserti C, Belanger MP, et al. Gender-differences in myocardial adaptation to afterload in normotensive and hypertensive rats. Hypertension. 2000;36:774-779.
24. Slama M, Ahn J, Varagic J, et al. Long term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age. Am J Physiol. 2004;286:H181-H185. (Pubitemid 38049478)
25. Tsotetsi OJ, Woodiwiss AJ, Netjhardt M, et al. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats. Hypertension. 2001;38: 846-851. (Pubitemid 34258681)
26. Swynghedauw B, Delcayre C, Cheav SL, et al. Biological basis of diastolic dysfunction of the hypertensive heart. Eur Heart J. 1992; 13(Suppl D):2-8.
27. Litwin SE, Katz SE, Weinberg EO, et al. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995;91: 2642-2654.
28. Escudero EM, Camilión de Hurtado MC, Pérez NG, et al. Echocardio-graphic assessment of left ventricular midwall mechanics in spontane-ously hypertensive rats. Eur JEchocardiogr. 2004;5:169-175. (Pubitemid 38779967)
29. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 1991;69: 107-115.
30. Conrad CH, Brooks WW, Hayes JA, et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensiverat Circulation. 1995;91:161-170.
31. Boluyt MO, Bing OHL. Matrix gene expression and decompensated heart failure: the aged SHR model. Cardiovasc Res. 2000;46:239-249. (Pubitemid 30204595)
32. Crabos M, Coste P, Paccalin M, et al. Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol. 1997;29:55-65. (Pubitemid 27129130)
33. Brooksby P, Levi AJ, Jones JV The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat JHypertens. 1993;11:611-622. (Pubitemid 23225204)
34. Cerbai E, Barbieri M, Li Q, et al. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hyperten-sive rats of different ages. Cardiovasc Res. 1994;28:1180-1187. (Pubitemid 24264724)
35. Cerbai E, Crucitti A, Sartiani L, et al. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. Cardiovasc Res. 2000;45:388-396. (Pubitemid 30069504)
36. Sridhar A, Dech SJ, Lacombe VA, et al. Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats. Am J Physiol. 2006;291:H2192-H2198.
37. Chevalier B, Heudes D, Heymes C, et al. Trandolapril decreases prevalence of ventricular ectopic activity in middle-aged SHR. Circulation. 1995;92:1947-1953.
38. Ganten U, Schroder G, Witt M, et al. Sexual dimorphism of blood pressure in spontaneously hypertensive rats. JHypertens. 1989;7:721-726.
39. Nigro D, Fortes ZB, Scivoletto R, et al. Sex-related differences in the response of spontaneously hypertensive rats to angiotensin-converting enzyme inhibitor Endothelium. 1997;5:63-71. (Pubitemid 27165890)
40. Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates Hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31(1pt 2):435-439.
41. Devereux RB, Pickering TG, Alderman MH, et al. Left ventricular hypertrophy in hypertension: prevalence and relationship to pathophys-iologic variables. Hypertension. 1987;9(2pt 2):II53-II60.
42. Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women. JHypertens. 2002;20:S34-S38. (Pubitemid 34913765)
43. Forman DE, Cittadini A, Azhar G, et al. Cardiac morphology and function in senescent rats: gender-related differences. JAm Coll Cardiol. 1997;30: 1872-1877. (Pubitemid 27521276)
44. Jazbutyte V, Hu K, Kruchten P, et al. Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension. 2006;48:579-586. (Pubitemid 44843859)
45. Giummelly P, Lartaud-Idjouadiene I, Marque V, et al. Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats. Hypertension. 1999;34:207-211. (Pubitemid 29409216)
46. Marque V, Kieffer P, Atkinson J, et al. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertension. 1999;34:415-422. (Pubitemid 29426757)
47. Douglas PS, Katz SE, Weinberg EO, et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. JAm Coll Cardiol. 1998;32:1118-1125. (Pubitemid 28459608)
48. Tamura T, Said S, Gerdes AM. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension. 1999;33:676-680. (Pubitemid 29091646)
49. Gardner JD, Brower GL, Janicki JS. Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail. 2002;8:101-107. (Pubitemid 34521420)
50. Luchner A, Bröckel U, Muscholl M, et al. Gender-specific differences of cardiac remodelling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res. 2002;53:720-727. (Pubitemid 34175264)
51. Renna BF, MacDonnell SM, Reger PO, et al. Relative systolic dysfunction in female spontaneously hypertensive rat myocardium. J Appl Physiol. 2007;103:353-358. (Pubitemid 47092311)
52. Mirsky I, Pfeffer JM, Pfeffer MA, et al. The contractile state as the major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensiverat CircRes. 1983;53:767-778. (Pubitemid 14219939)
53. Capasso JM, Remily RM, Smith RH, et al. Sex differences in the myocardial contractility in the rat. Basic Res Cardiol. 1983;78:156-171. (Pubitemid 13127159)
54. 2+. Eur J Pharmacol. 1998;361:73-77. (Pubitemid 28522160)
55. Weinberg EO, Thienelt CD, Katz SE, et al. Gender differences in molecular remodelling in pressure overload hypertrophy. J Am Coll Cardiol. 1999;34:264-273.
56. Gardner JD, Brower GL, Janicki JS. Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats. J Appl Physiol. 2005;99:1378-1383. (Pubitemid 43014343)
57. Gardner JD, Murray DB, Voloshenyuk TG, et al. Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am JPhysiol. 2010;298:H497-H504.
58. Katz SD, Schwarz M,YeunJ, etal. Impairedacetylcholine- mediatedvasodilation in patients with congestive heart failure. Circulation. 1993;88:55-61.
59. Pourageaud F, Freslon J. Impaired endothelial relaxations induced by agonists and flow in spontaneously hypertensive rat compared to Wistar-Kyoto rat perfused coronary arteries. J Vasc Res. 1995;32: 190-199.
60. Linz W, Wohlfart P, Schoelkens BA, et al. Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension. 1999;34:291-295. (Pubitemid 29409230)
61. Böhm M, Beuckelmann D, Diet F, et al. Properties of cardiac a-and b-adrenoceptors in spontaneously hypertensive rats. Naunyn Schmiede-bergs Arch Pharmacol. 1988;338:383-391. (Pubitemid 19002184)
62. Brown L, Ooi S, Lau K, et al. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol. 2000;27:263-269. (Pubitemid 30194163)
63. Nava E, Farre AL, Moreno C, et al. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. JHypertens. 1998;16: 609-615. (Pubitemid 28230549)
64. Kojda G, Kottenberg K, Hacker A, et al. Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long term hypertension in rats. Pharm Acta Helv. 1998;73:27-35. (Pubitemid 28340233)
65. Wu R, Millette E, Wu L, et al. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorti-costerone acetate-salt hypertensive rats. J Hypertens. 2001;19: 741-748. (Pubitemid 32289554)
66. Lakshmi SV, Padmaja G, Kuppusamy P, et al. Oxidative stress in cardiovascular disease. Ind J Biochem Biophys. 2009;46:421-440.